Santecure Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 05-01-2025
- Paid Up Capital ₹ 2.00 M
as on 05-01-2025
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -20.69%
(FY 2016)
- Profit 30.76%
(FY 2016)
- Ebitda 5.12%
(FY 2016)
- Net Worth 1.78%
(FY 2016)
- Total Assets 15.70%
(FY 2016)
About Santecure Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Manpreet Singh and Rajesh Kumar serve as directors at the Company.
- CIN/LLPIN
U24232PB2014PTC038654
- Company No.
038654
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Mohali, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Santecure Life Sciences Private Limited offer?
Santecure Life Sciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pharma & Bioanalytical Services, PCD Pharma Franchise, Mineral Supplement, Calcium Tablet, Third Party Manufacturing Consultancy, Pharmaceutical Contract Manufacturing Services, Pharma Franchise, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Santecure Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manpreet Singh  | Director | 03-Jan-2019 | Current |
| Rajesh Kumar | Director | 26-Jul-2019 | Current |
Financial Performance of Santecure Life Sciences.
Santecure Life Sciences Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 20.69% decrease. The company also saw a substantial improvement in profitability, with a 30.76% increase in profit. The company's net worth moved up by a moderate rise of 1.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Santecure Life Sciences?
In 2016, Santecure Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Santecure Life Sciences?
Unlock and access historical data on people associated with Santecure Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Santecure Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Santecure Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
